1,581
Views
10
CrossRef citations to date
0
Altmetric
Research Paper

Cytotoxic substituted indolizines as new colchicine site tubulin polymerisation inhibitors

, , , , ORCID Icon, , , , , ORCID Icon & ORCID Icon show all
Pages 1581-1595 | Received 17 May 2020, Accepted 19 Jul 2020, Published online: 04 Aug 2020

Figures & data

Figure 1. Design in the series of the target indolizine derivatives.

Figure 1. Design in the series of the target indolizine derivatives.

Figure 2. Effects of compounds 11a, 11b, 11k, 14a, 15a, and 15j (10−5 M) on microtubule dynamics using Paclitaxel (10−5 M) as microtubule stabilising agent and Phenstatin (10−5 M) as microtubule destabilising agent.

Figure 2. Effects of compounds 11a, 11b, 11k, 14a, 15a, and 15j (10−5 M) on microtubule dynamics using Paclitaxel (10−5 M) as microtubule stabilising agent and Phenstatin (10−5 M) as microtubule destabilising agent.

Scheme 1. Synthesis pathway for indolizines 11a–l.

Scheme 1. Synthesis pathway for indolizines 11a–l.

Scheme 2. Synthesis of indolizines 14a–d.

Scheme 2. Synthesis of indolizines 14a–d.

Scheme 3. Synthesis of indolizines 15a–i.

Scheme 3. Synthesis of indolizines 15a–i.

Table 1. Results of the in vitro growth inhibition (GI %) of tested compounds against human cancer cell lines in the single-dose assayTable Footnotea.

Table 2. Results of the 5-dose in vitro human cancer cell growth inhibitionTable Footnotea for compounds 11a, 15a, and 15j and positive control Phenstatin.

Table 3. Binding orientation, energy, and amino acid contacts for tested compounds, as predicted by molecular docking experiments.

Supplemental material

Supplemental Material

Download PDF (1.2 MB)